Trial intelligence / Profile preview

Bevacizumab + Chemotherapy in Elderly Patients With Metastatic Colorectal Cancer

NCT01900717Phase 2Completed

Sponsor
Centre Hospitalier Universitaire Dijon Bourgogne
Start
Jul 2011
Primary completion
May 2015
Modality
Monoclonal Antibodies
Countries
1
01

Overview

A Phase 2 trial of bevacizumab in colorectal adenocarcinoma, sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Started Jul 2011; status: completed.

02

Drugs

bevacizumab
03

Conditions

colorectal adenocarcinoma

Beyond the preview

Go deeper on NCT01900717.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01900717.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call